Patent ID: 8017110
Filing Date: 2011-09-13
Classification: A01N,A61K,A61L,A61M

Abstract:
1. A process for inhibiting self-repair of nucleic acid of pathogenic white blood cells, bacteria and/or viruses which may be contained in blood components comprising the steps of: adding to the blood components riboflavin acting as a photosensitizer at a final concentration of between about 50-500 μM; irradiating the blood components and riboflavin acting as a photosensitizer with light in a visible or UV range at an appropriate wavelength to activate the riboflavin acting as a photosensitizer to fragment the nucleic acid of the pathogenic white blood cells, bacteria and/or viruses to inhibit self-repair of the nucleic acid; and wherein the inhibition of nucleic acid self-repair caused by the photosensitizer and light is maintained over time such that the pathogenic white blood cells, bacteria and/or viruses will not reproduce in the blood components.